Correlation Between Kymera Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Kymera Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Monte Rosa.
Diversification Opportunities for Kymera Therapeutics and Monte Rosa
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kymera and Monte is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Monte Rosa
Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.24 times less return on investment than Monte Rosa. But when comparing it to its historical volatility, Kymera Therapeutics is 1.76 times less risky than Monte Rosa. It trades about 0.05 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 796.00 in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would earn a total of 64.00 from holding Monte Rosa Therapeutics or generate 8.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kymera Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Kymera Therapeutics |
| Monte Rosa Therapeutics |
Kymera Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Monte Rosa
The main advantage of trading using opposite Kymera Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals | Monte Rosa vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |